Conjugate Meningococcal Vaccines Development: GSK Biologicals Experience

por Miller, Jacqueline M., Mesaros, Narcisa, Van Der Wielen, Marie, Baine, Yaela
Publicado 2011

Antibody persistence and immune memory 15 months after priming with an investigational tetravalent meningococcal tetanus toxoid conjugate vaccine (MenACWY-TT) in toddlers and young...

por Knuf, Markus, Baine, Yaela, Bianco, Véronique, Boutriau, Dominique, Miller, Jacqueline M.
Publicado 2012

Author reply to “Heterologous mRNA-based COVID-19 booster strategies: Comment”

por Das, Rituparna, Hyer, Randall N., Burton, Paul, Miller, Jacqueline M., Kuter, Barbara J.
Publicado 2023

Antibody persistence up to 5 years after vaccination of toddlers and children between 12 months and 10 years of age with a quadrivalent meningococcal ACWY-tetanus toxoid conjugate...

por Vesikari, Timo, Forsten, Aino, Bianco, Veronique, Van der Wielen, Marie, Miller, Jacqueline M
Publicado 2015

Emerging heterologous mRNA-based booster strategies within the COVID-19 vaccine landscape

por Das, Rituparna, Hyer, Randall N., Burton, Paul, Miller, Jacqueline M., Kuter, Barbara J.
Publicado 2023

A randomized study to assess the immunogenicity, antibody persistence and safety of a tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in chi...

por Vesikari, Timo, Forstén, Aino, Boutriau, Dominique, Bianco, Véronique, Van der Wielen, Marie, Miller, Jacqueline M.
Publicado 2012

Randomized trial to assess the immunogenicity, safety and antibody persistence up to three years after a single dose of a tetravalent meningococcal serogroups A, C, W-135 and Y tet...

por Vesikari, Timo, Forstén, Aino, Boutriau, Dominique, Bianco, Véronique, Van der Wielen, Marie, Miller, Jacqueline M.
Publicado 2012

Immunogenicity and Safety of a Quadrivalent Meningococcal Serogroups A, C, W-135 and Y Tetanus Toxoid Conjugate Vaccine (MenACWY-TT) Administered to Adults Aged 56 Years and Older:...

por Dbaibo, Ghassan, El-Ayoubi, Nabil, Ghanem, Soha, Hajar, Farah, Bianco, Veronique, Miller, Jacqueline M., Mesaros, Narcisa
Publicado 2013

Long-term immunogenicity and safety after a single dose of the quadrivalent meningococcal serogroups A, C, W, and Y tetanus toxoid conjugate vaccine in adolescents and adults: 5-ye...

por Borja-Tabora, Charissa Fay Corazon, Montalban, Cecilia, Memish, Ziad A., Boutriau, Dominique, Kolhe, Devayani, Miller, Jacqueline M., Van der Wielen, Marie
Publicado 2015

Persistence of the immune response two years after vaccination with quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine (MenACWY-TT) in Asian adolescents

por Quiambao, Beatriz P., Jain, Hermant, Bavdekar, Ashish, Dubey, Anand Prakash, Kolhe, Devayani, Bianco, Véronique, Van der Wielen, Marie, Miller, Jacqueline M.
Publicado 2016

Antibody persistence up to 5 y after vaccination with a quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine in adolescents

por Quiambao, Beatriz P., Bavdekar, Ashish, Dubey, Anand Prakash, Jain, Hemant, Kolhe, Devayani, Bianco, Véronique, Miller, Jacqueline M., Van der Wielen, Marie
Publicado 2017

The safety profile of Haemophilus influenzae type b–Neisseria meningitidis serogroups C and Y tetanus toxoid conjugate vaccine (HibMenCY)

por Rinderknecht, Stephen, Bryant, Kristina, Nolan, Terry, Pavia-Ruz, Noris, Doniz, Carlos Aranza, Weber, Miguel Angel Rodriguez, Cohen, Christopher, Aris, Emmanuel, Mesaros, Narcisa, Miller, Jacqueline M.
Publicado 2012

Immunogenicity and safety of measles-mumps-rubella and varicella vaccines coadministered with a fourth dose of Haemophilus influenzae type b and Neisseria meningitidis serogroups C...

por Bryant, Kristina A., McVernon, Jodie, Marchant, Colin D., Nolan, Terry, Marshall, Gary S., Richmond, Peter, Marshall, Helen, Nissen, Michael, Lambert, Stephen B., Aris, Emmanuel, Mesaros, Narcisa, Miller, Jacqueline M.
Publicado 2012

Safety and Immunogenicity of a 100 μg mRNA-1273 Vaccine Booster for Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)

por Chalkias, Spyros, Schwartz, Howard, Nestorova, Biliana, Feng, Jing, Chang, Ying, Zhou, Honghong, Dutko, Frank J., Edwards, Darin K., Montefiori, David, Pajon, Rolando, Leav, Brett, Miller, Jacqueline M., Das, Rituparna
Publicado 2022

Comparison of the Safety and Immunogenicity of a Novel Quadrivalent Meningococcal ACWY-Tetanus Toxoid Conjugate Vaccine and a Marketed Quadrivalent Meningococcal ACWY-Diphtheria To...

por Halperin, Scott A., Baine, Yaela, Domachowske, Joseph B., Aggarwal, Naresh, Simon, Michael, Langley, Joanne M., McNeil, Shelly A., Friedland, Leonard R., Bianco, Veronique, Baccarini, Carmen I., Miller, Jacqueline M.
Publicado 2014

Evaluation of mRNA-1273 SARS-CoV-2 Vaccine in Adolescents

por Ali, Kashif, Berman, Gary, Zhou, Honghong, Deng, Weiping, Faughnan, Veronica, Coronado-Voges, Maria, Ding, Baoyu, Dooley, Jacqueline, Girard, Bethany, Hillebrand, William, Pajon, Rolando, Miller, Jacqueline M., Leav, Brett, McPhee, Roderick
Publicado 2021

Immunogenicity and Safety of 3 Formulations of a Respiratory Syncytial Virus Candidate Vaccine in Nonpregnant Women: A Phase 2, Randomized Trial

por Schwarz, Tino F, McPhee, Roderick A, Launay, Odile, Leroux-Roels, Geert, Talli, Jaak, Picciolato, Marta, Gao, Feng, Cai, Rongman, Nguyen, Thi Lien-Anh, Dieussaert, Ilse, Miller, Jacqueline M, Schmidt, Alexander C
Publicado 2019

Prospective clinical trial of hepatitis B vaccination in adults with and without type-2 diabetes mellitus

por Van Der Meeren, Olivier, Peterson, James T., Dionne, Marc, Beasley, Richard, Ebeling, Peter R., Ferguson, Murdo, Nissen, Michael D., Rheault, Paul, Simpson, Richard W., De Ridder, Marc, Crasta, Priya D., Miller, Jacqueline M., Trofa, Andrew F.
Publicado 2016

Immune response to SARS-CoV-2 after a booster of mRNA-1273: an open-label phase 2 trial

por Chu, Laurence, Vrbicky, Keith, Montefiori, David, Huang, Wenmei, Nestorova, Biliana, Chang, Ying, Carfi, Andrea, Edwards, Darin K., Oestreicher, Judy, Legault, Holly, Dutko, Frank J., Girard, Bethany, Pajon, Rolando, Miller, Jacqueline M., Das, Rituparna, Leav, Brett, McPhee, Roderick
Publicado 2022

Safety, immunogenicity and antibody persistence of a bivalent Beta-containing booster vaccine against COVID-19: a phase 2/3 trial

por Chalkias, Spyros, Eder, Frank, Essink, Brandon, Khetan, Shishir, Nestorova, Biliana, Feng, Jing, Chen, Xing, Chang, Ying, Zhou, Honghong, Montefiori, David, Edwards, Darin K., Girard, Bethany, Pajon, Rolando, Dutko, Frank J., Leav, Brett, Walsh, Stephen R., Baden, Lindsey R., Miller, Jacqueline M., Das, Rituparna
Publicado 2022